trending Market Intelligence /marketintelligence/en/news-insights/trending/zaZWXem1vqsQv3J6xiultA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Tilray, Novartis unit to jointly distribute medical cannabis worldwide

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Tilray, Novartis unit to jointly distribute medical cannabis worldwide

Tilray Inc., a Canadian cannabis company, has entered an agreement with Novartis AG's Swiss generics and biosimilars unit Sandoz AG to increase the availability of medical cannabis worldwide, as of Dec. 18.

The global collaboration agreement, which will focus on the commercialization and distribution of Tilray's non-smokable and non-combustible medical cannabis products, expands on a previous partnership between Tilray and Sandoz Canada Inc. to co-market products in Canada.

Under the new partnership, Tilray and Sandoz AG will jointly distribute medical cannabis in regions where the substance is approved for medical use. The companies may co-brand products and jointly develop new products as well.

Nanaimo, British Columbia-based Tilray, which now trades on the Nasdaq Global Select Market, currently has products available in 12 countries. In addition to producing medical marijuana, Tilray plans to provide cannabis products for Canada's adult recreational use market.